Search Results - "Shestakova, V. V."

Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program) by Kosiborod, Mikhail, Gomes, Marilia B, Nicolucci, Antonio, Pocock, Stuart, Rathmann, Wolfgang, Shestakova, Marina V, Watada, Hirotaka, Shimomura, Iichiro, Chen, Hungta, Cid-Ruzafa, Javier, Fenici, Peter, Hammar, Niklas, Surmont, Filip, Tang, Fengming, Khunti, Kamlesh

“…The global prevalence of type 2 diabetes-related complications is not well described. We assessed prevalence of vascular complications at baseline in DISCOVER…”
Get full text

Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review by Khunti, Kamlesh, Gomes, Marilia B., Pocock, Stuart, Shestakova, Marina V., Pintat, Stéphane, Fenici, Peter, Hammar, Niklas, Medina, Jesús

“…Aims Therapeutic inertia, defined as the failure to initiate or intensify therapy in a timely manner according to evidence‐based clinical guidelines, is a key…”
Get full text

Vascular complications of diabetes mellitus worldwide and in Russia: The path of 100 years. A review by Shestakova, M V, Severina, A S

“…With the discovery and introduction of insulin, the "palette" of life-threatening conditions for patients with diabetes mellitus has changed dramatically: from…”
Get full text

Endothelial dysfunction in patients with obesity and type 2 diabetes mellitus or normoglycemia: assessment of specific markers by Pokrovskaya, E. V., Shestakova, E. A., Shestakova, M. V.

“…BACKGROUND : One of the function of the endothelium is the maintenance of body's homeostasis. Endothelial dysfunction is known to be profoundly implicated in…”
Get full text

Regulation of Adipose Tissue Stem Cells Angiogenic Potential by Tumor Necrosis Factor-Alpha by Zubkova, Ekaterina S., Beloglazova, Irina B., Makarevich, Pavel I., Boldyreva, Maria A., Sukhareva, Olga Yu, Shestakova, Marina V., Dergilev, Konstantin V., Parfyonova, Yelena V., Menshikov, Mikhail Yu

“…ABSTRACT Tissue regeneration requires coordinated “teamwork” of growth factors, proteases, progenitor and immune cells producing inflammatory cytokines…”
Get full text

AICAR Protects Vascular Endothelial Cells from Oxidative Injury Induced by the Long-Term Palmitate Excess by Samsonov, Mikhail V, Podkuychenko, Nikita V, Khapchaev, Asker Y, Efremov, Eugene E, Yanushevskaya, Elena V, Vlasik, Tatiana N, Lankin, Vadim Z, Stafeev, Iurii S, Skulachev, Maxim V, Shestakova, Marina V, Vorotnikov, Alexander V, Shirinsky, Vladimir P

“…Hyperlipidemia manifested by high blood levels of free fatty acids (FFA) and lipoprotein triglycerides is critical for the progression of type 2 diabetes (T2D)…”
Get full text

Risk factors for COVID-19 case fatality rate in people with type 1 and type 2 diabetes mellitus: A nationwide retrospective cohort study of 235,248 patients in the Russian Federation by Shestakova, M. V., Vikulova, O. K., Elfimova, A. R., Deviatkin, A. A., Dedov, I. I., Mokrysheva, N. G.

“…The aim To study the association of demographic, clinical, and laboratory factors and the use of glucose-lowering drugs and anti-coronavirus disease (COVID-19)…”
Get full text

The prevalence of type 2 diabetes mellitus in the adult population of Russia (NATION study) by Dedov, Ivan I., Shestakova, Marina V., Galstyan, Gagik R.

“…Aim. To estimate the prevalence of type 2 diabetes mellitus (T2DM) in Russian adults.Materials and methods. NATION was a national, epidemiological,…”
Get full text

Ala54Thr polymorphism of the fatty acid transporter gene ( FABP2 ) in patients with type 2 diabetes mellitus in Yakutia by Sydykova, L A, Pavlova, N I, Bochurov, A A, Alekseev, V A, Krylov, A V, Kurtanov, K A, Shestakova, M V

“…To study the contribution of the Ala54Thr genetic polymorphism of the gene to the risk of developing type 2 diabetes mellitus among the Yakut population. The…”
Get full text

Diabetes mellitus in the Russian Federation: dynamics of epidemiological indicators according to the Federal Register of Diabetes Mellitus for the period 2010–2022 by Dedov, I. I., Shestakova, M. V., Vikulova, O. K., Zheleznyakova, A. V., Isakov, M. A., Sazonova, D. V., Mokrysheva, N. G.

“…BACKGROUND. The clinical and epidemiological characteristics of diabetes mellitus (DM) and the quality of its therapy are the key prognostic dominant that…”
Get full text

Prognostic factors for the carbohydrate metabolism normalization in patients with type 2 diabetes mellitus and obesity using liraglutide 3.0 mg per day by Sklyanik, Igor A., Shestakova, Marina V.

“…Background. Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are innovative drugs that effectively reduce glycemic levels and overweight in patients with…”
Get full text

Epidemiological characteristics of diabetes mellitus in the Russian Federation: clinical and statistical analysis according to the Federal diabetes register data of 01.01.2021 by Dedov, I. I., Shestakova, M. V., Vikulova, O. K., Zheleznyakova, A. V., Isakov, M. А.

“…BACKGROUND .  One of the priority directions in the development of the health care system is to reduce the medical and social damage caused by the increase in…”
Get full text

Effectiveness of gliclazide MR 60 mg in the management of type 2 diabetes: analyses from the EASYDia trial by Leiter, Lawrence A, Shestakova, Marina V, Satman, Ilhan

“…Although the number of antihyperglycemic agents has expanded significantly, sulfonylureas (in particular gliclazide) remain an important option because of a…”
Get full text

Treatment of type 2 diabetes mellitus worldwide: Baseline patient characteristics in the global DISCOVER study by Gomes, Marilia B., Rathmann, Wolfgang, Charbonnel, Bernard, Khunti, Kamlesh, Kosiborod, Mikhail, Nicolucci, Antonio, Pocock, Stuart J., Shestakova, Marina V., Shimomura, Iichiro, Tang, Fengming, Watada, Hirotaka, Chen, Hungta, Cid-Ruzafa, Javier, Fenici, Peter, Hammar, Niklas, Surmont, Filip, Ji, Linong

“…To describe the characteristics and treatment of patients with type 2 diabetes mellitus initiating a second-line glucose-lowering therapy in the global…”
Get full text

Angiogenesis system, as a part of endothelial dysfunction in patients with diabetes mellitus type 2: relationship with obesity by Severina, A S, Shestakova, M V

“…To investigate parameters of angiogenesis system in patients with diabetes mellitus and their relationship with obesity. 104 patients with diabetes mellitus…”
Get full text

Effects of GLP-1RAs on cardiovascular outcomes in patients with type 2 diabetes mellitus: review of real-world data on target populations from diabetes registry in Russian Federation by Vikulova, O. K., Galstyan, G. R., Shestakova, M. V.

“…RATIONALE. Over the past 20 years the prevalence of type 2 diabetes in Russia has more than doubled and reached 4.43 million people in 2020, while the growth…”
Get full text

Incidence rates and predictors of microvascular and macrovascular complications in patients with type 2 diabetes: Results from the longitudinal global discover study by Arnold, Suzanne V, Khunti, Kamlesh, Tang, Fengming, Chen, Hungta, Cid-Ruzafa, Javier, Cooper, Andrew, Fenici, Peter, Gomes, Marilia B, Hammar, Niklas, Ji, Linong, Saraiva, Gabriela Luporini, Medina, Jesús, Nicolucci, Antonio, Ramirez, Larisa, Rathmann, Wolfgang, Shestakova, Marina V, Shimomura, Iichiro, Surmont, Filip, Vora, Jiten, Watada, Hirotaka, Kosiborod, Mikhail

“…Micro- and macrovascular complications are a major cause of morbidity and mortality in people with type 2 diabetes (T2D). We sought to understand the global…”
Get full text

Sub-analyses of the DAPA-CKD study: new data on the use of sodium-glucose cotransporter type 2 inhibitor in the treatment of chronic kidney disease by Shamkhalova, Minara S., Sukhareva, Olga Y., Shestakova, Marina V.

“…Sodium-glucose cotransporter inhibitors updated their position in the therapy of patients with type 2 diabetes mellitus due to proven nephro- and…”
Get full text

Combination of familial partial lipodystrophy (Dunnigan-Cobberling syndrome) with pulmonary sarcoidosis by Frolkova, N. V., Koksharova, E. O., Vasiluev, P. A., Smirnova, O. M., Shestakova, M. V.

“…Lipodystrophy syndromes are a heterogeneous group of extremely rare, inherited or acquired disorders that are characterized by total or partial fat loss or its…”
Get full text

Metformin discontinuation in patients beginning second-line glucose-lowering therapy: results from the global observational DISCOVER study programme by Khunti, Kamlesh, Gomes, Marilia B, Kosiborod, Mikhail, Nicolucci, Antonio, Pocock, Stuart, Rathmann, Wolfgang, Shestakova, Marina V, Shimomura, Iichiro, Watada, Hirotaka, Chen, Hungta, Cid-Ruzafa, Javier, Fenici, Peter, Hammar, Niklas, Tang, Fengming, Ji, Linong

“…ObjectivesTo evaluate the extent to which patients with type 2 diabetes discontinue metformin therapy when initiating second-line treatment and factors…”
Get full text